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Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds, United KingdomABSTRACT Delineating the nanoscale properties and the dynamic assembly and disassembly behaviors of amyloid fibrils is
key for technological applications that use the material properties of amyloid fibrils, as well as for developing treatments of
amyloid-associated disease. However, quantitative mechanistic understanding of the complex processes involving these
heterogeneous supramolecular systems presents challenges that have yet to be resolved. Here, we develop an approach
that is capable of resolving the time dependence of fibril particle concentration, length distribution, and length and position
dependence of fibril fragmentation rates using a generic mathematical framework combined with experimental data derived
from atomic force microscopy analysis of fibril length distributions. By application to amyloid assembly of b2-microglobulin
in vitro under constant mechanical stirring, we present a full description of the fibril fragmentation and growth behavior, and
demonstrate the predictive power of the approach in terms of the samples’ fibril dimensions, fibril load, and their efficiency to
seed the growth of new amyloid fibrils. The approach developed offers opportunities to determine, quantify, and predict the
course and the consequences of amyloid assembly.INTRODUCTIONAmyloid fibrils represent a class of supramolecular particles
self-assembled from a variety of naturally occurring or
designed proteins or peptide sequences (1–5). These nano-
structures are associated with numerous devastating human
disorders, such as type II diabetes mellitus, Alzheimer’s and
Parkinson’s diseases (1). Despite these assemblies being
linked to disease, amyloid fibril nanostructures have favor-
able molecular and material properties that could be har-
nessed for technological applications. Nature has itself
adopted amyloid structures for varied structural and func-
tional roles to use their favorable properties for the benefit
of living organisms (e.g. 6–8). If amyloid assembly and
disassembly could be better understood in mechanistic
terms, and controlled, the diseases that involve amyloid
formation may be more effectively combated, and the
molecular and material properties that amyloid fibrils
possess could be harnessed as engineered high-performance
bionanomaterials (3).
Amyloid fibrils share a common cross-beta coremolecular
architecture (5), with a highly ordered network of intermo-
lecular hydrogen bonds that make them extremely stable
structures (3). Despite having a width in the order of ~10
nanometers, fibrils can grow up to several micrometers in
length in vitro (9–12). A typical amyloid sample, indepen-Submitted June 19, 2013, and accepted for publication October 29, 2013.
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geneous mixture that contains monomers, small oligomers,
and fibrillar species with a wide range of sizes. There are
numerous studies showing that different species formed
during amyloid assembly are potentially associated with
the pathogenic properties connected to amyloid disease,
such as the potential to cause membrane damage, cytotox-
icity, and organ dysfunction (e.g. 13–17). In the case of
amyloid fibrils, variations in fibril length distribution can
lead to different biological responses, ranging from relatively
inert material involving long and/or entangled fibril poly-
mers to shorter, freely diffusing cytotoxic and/or propagating
particles (12,18,19). The potential for short fibrillar particles
to elicit cytotoxicity, to generate further cytotoxic species by
disassembly, or to seed new amyloid growth and rapidly
increase fibril load emphasizes the importance of mecha-
nistic understanding of amyloid fibril assembly, disassembly,
and their balance. Analyses of amyloid behavior therefore
require the development of tools for the precise characteriza-
tion of the species distributions of highly heterogeneousmix-
tures in intricate detail and how this varies with time, growth
conditions, protein concentration, and solution environment.
Recent advances based on classical assembly theories
(e.g. 20–22) have resulted in the development of mathemat-
ical models that are increasingly better at describing amy-
loid assembly reactions (23–26). These models, together
with advances in experimental and computational studies
(e.g. 24,27–31) have increased our understanding of the
molecular mechanisms and nanoscale properties of amyloid
assembly. In particular, secondary fibril fragmentation
processes have been identified as a key mechanism in accel-
erating the formation of amyloid, in addition to primary
nucleation and growth (23,25,31). Fibril fragmentation ishttp://dx.doi.org/10.1016/j.bpj.2013.10.034
2812 Xue and Radfordalso appreciated as a process of fundamental importance in
creating small fibrillar species that can elicit enhanced
seeding and cytotoxic potential (12,18). Although numerical
and analytical solutions to models of amyloid assembly
involving fibril breakage (23,25) have been proposed, exper-
imental characterization of the mechanisms and rates of
fibril fragmentation, and deconvolution of its effects from
primary fibril elongation during their growth, remain chal-
lenging and unresolved. The challenges, thus far, have
prevented systematic testing of the behavior of amyloid
systems and the full characterization and prediction of the
course of amyloid assembly.
Here, we describe a generic master equation-based mathe-
matical framework, which we combine with experimental
data obtained by tapping-mode atomic force microscopy
(TM-AFM) imaging and image analysis capable of single
fibril particle characterization, effectively bridging theory
with experimental data of high informational content. We
then apply our approach to the in vitro assembly of b2-micro-
globulin (b2m) fibrils, which allowed the determination of
particle concentration and length distribution of fibrils as
they break, and the rate of fibril fragmentation as a function
of fibril length and breakage position. We demonstrate that
deconvoluting these key molecular and mechanistic proper-
ties permits the predictive power to assess the assembly
rate, the length distribution, the fibril load, and the seeding ef-
ficiency of amyloid fibril material. In summary, we show that
our approach, involving systems modeling combined with
TM-AFM image analysis of fibril length distributions during
fibril breakage and fibril elongation experiments, together
allow a full description of the amyloid fibrils’ fragmentation
and growth behavior during amyloid assembly.MATERIALS AND METHODS
Generation and controlled fragmentation of b2m
fibril samples
In vitro-generated b2m fibril samples were prepared using lyophilized re-
combinant wild-type monomeric b2m as previously described (12) and as
detailed in the Supporting Material. Fibril fragmentation was achieved by
mechanical perturbation. All mechanical agitation experiments were per-
formed using a method involving stirring of a 500 ml of fibril samples in
1.5-ml glass vials containing 3  8-mm polytetrafluoroethylene-coated
magnetic stirring bars using a custom-made precision stirrer with accurate
rpm readout (custom-built by the workshop of the School of Physics and
Astronomy, University of Leeds). Stirring was performed at 1,000 rpm,
25C, which generates turbulent flow in the sample that distribute the agita-
tion action to prevent the alignment of fibrils and achieve fibril fragmenta-
tion on an experimentally accessible timescale. Such a stirring method also
allows discrete samples to be taken at well-controlled time points of frag-
mentation and assembly so that the time course can be readily followed
and analyzed.TM-AFM imaging and quantitative image analysis
b2m fibrils were deposited on mica by incubating freshly cleaved mica
surface with 20 mL of a solution containing fibril sample diluted with sterileBiophysical Journal 105(12) 2811–2819filtered and deionized water to 0.4 mM total monomer equivalent concentra-
tion of fibrils for 5 min at 25C. Great care was taken to minimize additional
mechanical perturbations through sample handling and pipetting. The mica
surface was subsequently gently washed with 1 mL sterile-filtered deion-
ized water and dried under a gentle stream of nitrogen gas. All TM-AFM
height images were collected in air using a Dimension 3100 Scanning Probe
Microscope (Veeco Instruments), a MPF-3D Atomic Force Microscope
(Asylum Research), or a Bruker MultiMode 8 Scanning Probe Microscope
(Bruker) using PPP-NCLR cantilever probes (Nanosensors, Neuchatel,
Switzerland) with a nominal force constant of 48 N/m. Height images
were collected at a resolution of 1024  1024 pixels over 10  10 mm
surface area and processed using supplied software for each instrument to
remove sample tilt and scanner bow. The length of individual fibril parti-
cles, L, was extracted and measured using automated scripts written in
MATLAB (The MathWorks, Natick, MA). Because the efficiency of fibril
deposition on surface substrate and successful measurement of length of
individual fibrils depend on fibril length, the normalized length distribution
of the fibrils in the bulk samples corrected for the length bias of surface im-
aging, Pc, was determined as previously described (12,32).Fibril growth monitored by thioflavin T (ThT)
fluorescence
Fibril growth reactions were monitored by ThT fluorescence in black flat-
bottom uncoated 96-well plates using a BMG LABTECH FLUOStar
Optima plate reader at 25C as previously described (23). Fibril growth
reactions were initiated manually and 10 mMThTwas used in each reaction
with 100 mL total volume in each well.Numerical modeling and analysis
Numerical modeling, image analysis, parameter estimation, and statis-
tical analysis were carried out using scripts written in MATLAB (The
MathWorks). The master equation approach and all equations used for
data analysis are explained and justified in the Supporting Material. Numer-
ical integrations of the master equation were solved for fibril species
containing up to 20,000 monomeric units, and concentration errors intro-
duced by truncation of larger species were <1%. Parameter estimation
with the resulting time evolution of species distributions were performed
by the maximum likelihood estimation (MLE) method described previously
(32). Parameters were optimized using the simplex direct search algorithm.
Model comparison were performed using the Akaike information criterion
(AIC) as described previously (23) with the corrected AIC (AICc) scores
calculated as AICc ¼ 2 M  2 ln(L ) þ 2M(Mþ1)/(N-M-1) where N is
the number of data points and M is the number of fitted parameters and
L is the maximized likelihood function from the MLE analysis of length
distributions. Error analysis of the best-fit model was carried out using
the Jackknife method performed on each of the fibril fragmentation time
points.RESULTS
Construction of a generic framework for
assembly models
To approach a full yet flexible description of the dynamic
mechanism of amyloid assembly, vital for understanding
and predicting amyloid formation both in vivo and
in vitro, we use a master equation approach that can describe
every possible forward and backward step involving every
possible species in the assembly system. The master
Fibril Breakage and Particle Concentration 2813equation of assembly was setup and expressed as the
following:
dc
dt
¼ k$c (1)
with the vector c representing the species distribution in the
molar number concentration unit, and k, sometimes referred
to as the kernel, representing a matrix capable of describing
the mechanism of any assembly reaction (detailed in the
Supporting Material). In terms of amyloid assembly, previ-
ous investigations have indicated that the fibrillar products
are formed through mechanisms dominated by a forward
templated growth reaction by monomer addition as well as
a backward fibril fragmentation reaction (23,25). The matrix
k for amyloid assembly can therefore be separated and
expressed as k z kgrowth þ kfrag. If the detailed species
distribution, c, could be quantified for the assembly of fibrils
under experimental conditions where growth or fragmenta-
tion each independently dominate, k representing the as-
sembly and disassembly mechanism could be constructed
and used to describe and to predict properties of amyloid
assembly as well as the mechanical stability of amyloid fi-
brils toward fragmentation.FIGURE 1 b2m fibril fragmentation monitored by TM-AFM imaging.
Typical AFM height images of the fibril samples as a function of fragmen-
tation reaction time are shown in the left column with scale bars shown
below the images. The left side images show half (5  10 mm) of
1024  1024 pixel, 10  10 mm images. The right side images show a
4-magnified region on the same images. Normalized histograms of the
length distribution of each fibril sample are shown in the right column,
with the red lines indicating the best-fit time evolution of the length distri-
butions as fragmentation proceeds according to kFrag resulting from model
number 5 in Table S1. The fibril length distribution histograms are each
constructed from 460 to 1200 individual fibril particles on 4–16 images.
The scale corresponding to the fibril particle concentrations for each sample
is shown to the right of the plots. To see this figure in color, go online.Fibril particle concentration and distribution
To bridge the previous theoretical framework (Eq. 1) with
experimental data required to extract mechanistic informa-
tion regarding amyloid fibril fragmentation and growth,
we first developed an image analysis method that allowed
us to determine the distribution of the particle number con-
centration (in molar units) for discrete fibril species of
different length using TM-AFM. We then used this
approach to characterize the fibril fragmentation and exten-
sion mechanisms of b2m amyloid fibrils formed in vitro
(12,33). b2m amyloid assembly is involved in systemic dial-
ysis-related amyloidosis (34) and an autosomal dominant,
hereditary variant of systemic amyloidosis (35). In this
study b2m fibrils were formed from acid unfolded b2m
monomers at pH 2.0. The fibrils that result show all the
typical physical, structural, and tinctorial characteristics of
amyloid formed in vivo (33).
To resolve the molar particle concentration cF of the
sample containing long straight, unfragmented b2m fibrils,
which is inherently highly heterogeneous in length, three
independent pieces of information were used. I), The fibril
length distribution, Pc, of the fibril particles f in the b2m
fibril sample (Fig. 1, top row black line), which was
measured using TM-AFM and single particle length, L,
measurements, corrected for the length dependent imaging
bias (32). II), The total monomer equivalent concentration
of the sample c1,tot, which in this case was 120 mM (deter-
mined before the start of the reaction using ultraviolet-
absorbance). III) The mass per unit length of fibrils, whichin the case of the b2m fibrils employed here has been
measured previously using scanning transmission electron
microscopy and estimated to be 53 kDa/nm based on the
modal value for the dominant fibril population (10). This
value is equivalent to around 4.5 monomers per nm length:
Nl ¼ 4.5 nm1. Combining these three pieces of informa-
tion, and assuming a negligible residual monomer concen-
tration in the fibril sample (consistent with previous
reports (36)), the molar fibril particle concentration for the
fibril sample, cF, was determined to be 2.7$10
8 M, using
the following equation (detailed in the SupportingMaterial).
cF ¼ c1;totP
f
Lf NlPc

Lf
 (2)
The detailed species distribution of the sample, c ¼ c(i) [M]
(i ¼1,2,3,.monomer units), was then established using the
length distribution by calculating the number of monomerBiophysical Journal 105(12) 2811–2819
2814 Xue and Radfordunits in each measured fibril using the known Nl (Eq. S2,
in the Supporting Material) followed by MLE using a
Weibull distribution model (32). The total fibril particle
concentration cF and the concentration of species of
different length in the species distribution are key character-
istics of the fibril sample that allow us to decipher the frag-
mentation behavior and the seeding potential of the fibrils.
The molar concentration of fibril particles can also be
used, for example, in comparing the cytotoxicity potential
of amyloid samples on a per particle (molar) basis.Length and position dependence of fibril
fragmentation
The characterization of the fibril species distribution and
molar particle concentration allowed us to next characterize
the mechanism of fibril fragmentation (Fig. 2 a) by extract-
ing the matrix kFrag (Eq. 1, and the Supporting Material)
that describes how long straight b2m fibrils in our sample
are fragmented by mechanical perturbation. The rates of
fibril breakage under the conditions employed, indicative
of the fibrils’ stability toward fragmentation, were also
determined. As previously described (12), the preformed
long straight b2m fibril sample (500 ml) was put into a
1.5 ml chromatography glass vial with a 3  8 mm polyte-
trafluoroethylene-coated magnetic stirring bar and subjected
to turbulent agitation by stirring at a single constant speed ofFIGURE 2 Length and position dependence of the best-fit fibril fragmen-
tation model. (a) Schematic illustration of a fibril fragmentation reaction.
(b) The fragmentation rate matrix kFrag represented as a contour diagram,
showing the first order fragmentation rate constants as a function of fibril
length i, and position of breakage j, expressed as the number of monomers
or nanometers in the brackets. (c) The fibril fragmentation rate constant as a
function of fibril length for the best-fit fragmentation model. (d) Example of
fragmentation rate constant as a function of breakage position for a fibril of
2000 nm in length for the best-fit fragmentation model. In (c) and (d), the
shaded area indicates 95% confidence functional prediction bounds. The
dotted red line in (c) and (d) shows the results obtained using the Hill model
(37). To see this figure in color, go online.
Biophysical Journal 105(12) 2811–28191000 rpm (Materials and Methods). At different time points,
up to 30 h, a small aliquot of the sample was taken out and
immediately placed on freshly cleaved mica for analysis
using TM-AFM (12). The resulting fibril length distribu-
tions are plotted in Fig. 1.
To extract kFrag that contains both length- and position-
dependent rates information regarding the fibril fragmenta-
tion process, we fit numerical solutions of Eq. 1 to the time
evolution of the fibril length distributions experimentally
measured by single-particle TM-AFM imaging. We used
two independent and parallel approaches to resolve kFrag.
In the first approach numerical solutions of Eq. 1 obtained
using a series of kFrag with increasing complexity (see the
Supporting Material) were fit to the distribution data until
the goodness of fit did not improve with a further increase
in model complexity (Table S1, models 1–6). This approach
lets the information content of the data dictate a model that
can best describe the fibril fragmentation mechanism
without the need to assume a mechanism a priori. We started
with the simplest model that depicts the case where the
microscopic fragmentation rate constants for breakage
between each monomer is identical and is independent of
length or position (Table S1, model 1). Notably, this is a
frequently used assumption in existing amyloid assembly
models (25). In this case, the overall fragmentation rate con-
stant of a fibril of a given length, which is the sum of all
microscopic fragmentation rate constants for all possible
fragmentation sites between monomers in the fibril, is
linearly dependent on fibril length because the number of
fragmentation sites increases linearly with length. The
calculated length distributions of such a fragmentation
model, however, do not reproduce the measured fibril length
distributions, resulting in the model approaching an expo-
nential distribution that systemically deviates from the
data after ~5 h of fragmentation, especially for short fibril
particles of a few hundred nm in length (Fig. S1). The
complexity of kFragwas then increased in a stepwise manner
(detailed in the Supporting Material). The goodness of fit,
corrected for the increased complexity of kFrag in terms of
the number of fitted parameters, was quantified using AIC
with a lower AICc score indicating an overall better model
(23). A total of 6 kFrag, were tested in this manner until the
AICc score stopped decreasing as model complexity
increased (Table S1), indicating that the kFrag with the
lowest AICc score found is a likely description of the fibril
fragmentation mechanism that has a complexity supported
by the information content in the data. The best-fit (red lines
in Fig. 1) kFrag with the lowest AICc score is represented in
Fig. 2 b as a contour diagram. The first order fibril fragmen-
tation rate constant as a function of fibril length calculated
from this best-fit model is plotted in Fig. 2 c; accordingly,
the best fit kFrag represents a fibril fragmentation mechanism
where the breakage rate is dependent on fibril length in a
nonlinear manner. For example, under the conditions
employed, a fibril of 2 mm in length has an estimated
FIGURE 3 Determination of the second order fibril extension rate con-
stant, kþ. (a) Typical fibril growth reaction progress curves of reactions
seeded by fibril samples taken from the fragmentation reaction shown in
Fig. 1, monitored by ThT fluorescence. All curves are normalized to their
upper baselines (unnormalized traces are shown in Fig S2). The times
each sample was fragmented, before addition to excess monomer to stimu-
late fibril growth, are shown to the right. (b) Initial slope of the normalized
reaction progress curves versus fibril seed particle concentration. The error
bars indicate one standard error of four reaction replicates. The red line de-
notes a linear function fit to the data using a total least squares method. To
see this figure in color, go online.
Fibril Breakage and Particle Concentration 2815fragmentation rate constant of 1.1$104s1 (log(k/s1) ¼
3.7 5 0.2) corresponding to a half-life of ~6300 s or
<2 h. By contrast, a fibril of 200 nm in length has an esti-
mated fragmentation rate constant that is almost two orders
of magnitude lower at 2.9$106s1 (log(k/s1) ¼ 5.5 5
0.1) corresponding to a half-life of ~240,000s or ~66 h.
The results also indicate a substantial dependence of frag-
mentation on position, with the highest microscopic fibril
fragmentation rate constant displayed in the middle of
fibrils. Illustrated by the microscopic fibril fragmentation
rate constant as a function of the position of breakage for
a 2 mm fibril (Fig. 2 d), the estimated microscopic fibril
fragmentation rate constant in the middle of a 2 mm fibril
is 1.8$108s1 (log(k/s1) ¼ 7.7 5 0.2), whereas a
breakage of the same fibril resulting in a 200 nm and a
1800 nm fibril proceed with an estimated microscopic fibril
fragmentation rate constant of 5.5$109s1 (log(k/s1) ¼
8.3 5 0.2), >3 times less frequent.
In parallel, we tested a mechanistic model based on the
spontaneous breakage of stiff rods as proposed by Hill
(37). Fitting solutions of Eq. 1 obtained with a kFrag that
describes the Hill model (Table S1, model 7, and Fig. S1)
to the distributions of fibril lengths did not result in a signif-
icantly better fit compared with the best-fit result obtained
using the first approach as judged by the resulting AICc
score (Table S1). The dashed lines in Fig. 2, c and d,
show the length and position dependence of the fragmenta-
tion rate constants from the fit kFrag using the Hill model,
which displays a similar length and position dependence
to the best-fit model. The deviation from the best-fit model
may reflect the differences between the applied perturba-
tions and the equilibrium assumptions of the model, and
that the b2m fibrils are not completely rigid as stiff rods
but contain some degree of flexibility. Nevertheless, despite
the overall worse fit to the data, this mechanism-dependent
approach yielded a similar quantitative result in terms of the
fragmentation rates compared with our parallel approach,
confirming that the position- and length-dependent frag-
mentation mechanism and the fragmentation rate constants
obtained are robust.Determining the fibril elongation rate constant
The ability to determine the fibril concentration in molar
terms further allows the second order fibril elongation rate
constant free from contributions of secondary processes to
be determined in molar units on a per fibril particle basis
(Eq. S18). We seeded new monomer solutions of b2m
(12 mM) with small aliquots (2% w/w) of each of the b2m
fibril samples previously collected at different times of fibril
fragmentation ((12), Fig. 3, Fig. S2). The molar fibril
particle concentration of each of the seed samples was deter-
mined from their length distribution measured by TM-AFM
imaging, single particle image analysis, and Eq. 2 as
described previously. The reaction progress of the seededreactions was monitored by ThT fluorescence (12,23) and
the initial rate of fibril growth was plotted against the fibril
particle concentration added (Fig. 3, a and b). Because b2m
fibril growth is described by a monomer addition process
(23) and the initial rate of fibril growth is proportional to
the initial fibril particle concentration with a proportionality
constant of kþ (Eq. S18), kþ was quantified as the slope of
the line fit to the data points in Fig. 3 b. Total linear least
squares analysis (line in Fig. 3 b) yielded a kþ of 7.2$104
M-1s1 (log (kþ/M1s1)¼ 4.95 0.1) under the conditions
employed here for b2m fibril extension. This bimolecular
reaction rate constant is ~105 times lower than the maximum
diffusion-limited reaction rate constant based on estimates
using the Smoluchowski collision frequency factor for
collisions between spheres of similar dimensions to b2m
monomers undergoing diffusion, suggesting that approxi-
mately one in 105 molecular collisions with the fibrils re-
sults in attachment at fibril ends. It is important to note
that the determined value of kþ (by definition in Eq. S18)
is defined on a per M average fibril particle basis. Assuming
that extension competent sites operate independently, the
rate constant on per site basis is kþ/the average number of
extension sites per fibril.Predicting fibril length, concentration, extension,
and breakage
To test the predictive power gained from the mechanistic
analysis described previously and to demonstrate the ability
of the approach developed to deconvolute the fragmen-
tation and elongation rates of b2m fibril samples of different
length distributions, we performed a series of simulations
to forecast the outcomes of independent experiments
on independent fibril samples. First, we produced a new
fibril sample of different length distribution compared
with the previous sample (see the Supporting Material) forBiophysical Journal 105(12) 2811–2819
2816 Xue and Radfordvalidating our predictions. We characterized the fibril length
distribution of this sample as described previously (Fig. 4,
top right, Fig. S3, left). We then simulated how fibril frag-
mentation would proceed and change the length distribution
of this sample using the fragmentation model and rate
parameters derived previously (note that the solution condi-
tions, temperature, fragmentation conditions, and fibril
morphology were identical to the previous sample). This
enabled us to predict how the length distribution, as well
as the molar particle concentration, evolves as a function
of time (Fig. 4, left contour plot). To verify our predictions,
we performed the fibril fragmentation experiment on the
new sample and compared the experimentally measured
length distributions at selected time points with our predic-
tions (Fig. 4, right, Fig. S3). As shown in Fig. 4, the pre-
dicted length distributions follow closely the observed
distributions at experimentally verified time points, demon-
strating the ability of the model to predict the behavior of the
new sample.
Because the previous analysis enables the particle con-
centration to be predicted and how this increases when
fibrils fragment (Fig. S4), we next predicted the potential
of the previous fibril sample to seed the formation of new
fibrils and how this is enhanced by fibril fragmentation
(12). We then verified our predictions experimentally by
performing seeded fibril growth assays that mirror the sim-
ulations. Fig. 5 a (black þ) and b show the experimental
data of the seeding experiments, whereas Fig. 5 a (purple
line) and c show the predicted initial fibril growth rate as
a function of fragmentation time compared with the exper-FIGURE 4 Prediction of the time evolution of changes in fibril length
during fragmentation. Left contour diagram depicts predicted time evolu-
tion of the fibril length distribution of a fibril sample undergoing fibril frag-
mentation. Shown in the right column are purple lines indicating the
corresponding predicted length distributions as fragmentation precedes
compared with experimental validation data consisting of normalized histo-
grams of the length distribution of the fibril sample at the same time points,
determined by TM-AFM imaging and image analysis. The fibril length
distribution histograms shown are each constructed from 390 to 1200 indi-
vidual fibril particles on 4–10 images. The scale corresponding to the fibril
particle concentrations for each sample is shown to the right of the plots. To
see this figure in color, go online.
Biophysical Journal 105(12) 2811–2819imentally measured values. The results show that exploiting
the known fibril fragmentation and fibril extension rates, and
their associated kinetic constants on a fibril sample of
known initial length distribution and particle concentration
enables accurate and quantitative prediction of the reaction
progress. This included the increase in the ability of fibril
samples to seed the formation of new amyloid fibrils
following fragmentation, and the associated time-dependent
increase of fibril load.
Finally, to test the predictive power of our fibril fragmen-
tation and fibril growth models when applied simulta-
neously, we performed a simulation of a seeded fibril
growth under agitation by combining the rate constants for
the two processes in Eq. 1. A third independent sample
formed under agitation was used as the initial seed to test
the outcomes of this prediction versus the equivalent exper-
imental data, yielding the progress of fibril length as a func-
tion of time. Because the modeling results enable the rate of
fibril elongation to be compared with the rate of fibril
fragmentation, an initial faster fibril growth is expected
for this sample compared with the rate of breakage of short
fibril seeds. As a consequence, the simulations predict a
biphasic behavior wherein the average fibril length first
increases, followed by a phase dominated by the fragmenta-
tion of long fibrils into progressively shorter particles. This
results in a decelerating decrease in the average fibril length
(Fig. 6, Fig. S5) that reaches steady state after ~109 s
(~30 years, compared with the ThT traces of seeded growth,
which reached apparent steady state in <10 h). We then
performed an experiment mirroring the simulated reaction
and analyzed the average fibril length at selected times up
to 86,400 s (Fig. 6, Fig. S6). The experimental results
show, as predicted, a biphasic reaction in terms of fibril
length, confirming that the separately characterized fibril
fragmentation and growth models and associated kinetic
parameters together can predict complex composite amyloid
assembly processes.DISCUSSION
Recent advances in the experiments and theories of amyloid
assembly mechanisms have resulted in a number of impor-
tant developments in the field that have led to significantly
more sophisticated models and mechanistic insights into
the progress of amyloid assembly reactions (23–26,38,39).
One key finding is that fibril fragmentation is now recog-
nized as a critical process in accelerating fibril elongation,
reducing the lag time of assembly, and enhancing seeding
capacity (12,23,25). In addition, the recognition that fibril
fragmentation produces particles that may have new bio-
logical properties has increased excitement in our quest
to understand the mechanical properties of amyloid fibrils
and their fragmentation processes (3,12,32,40). Here, we
have characterized the mechanism of b2m fibril fragmen-
tation under mechanical perturbation through combined
FIGURE 5 Prediction of the ability of a fibril
sample to seed as fibril fragmentation proceeds.
(a) Predicted (purple line) and measured (black
cross) seeding efficiency characterized by the
initial slope of seeded fibril growth using the fibril
sample as a function of fragmentation time. The er-
ror bars on the measured data points indicate one
standard error from six replicate reactions. The
shaded area indicates 95% confidence functional
prediction bounds. (b) Typical fibril growth reac-
tion progress curves of reactions seeded by fibril
samples taken from the fragmentation reaction
shown in Fig. 4, monitored by ThT fluorescence.
All curves are normalized to their upper baselines. The time each sample was fragmented before addition to excess monomer to stimulate fibril growth
are shown in the inset. (c) Predicted initial slopes of seeded fibril growth compared with the measured initial slopes. The red shaded area contains data points
used to calculate the fibril elongation rate constant (the same as shown in Fig. 3 b) to indicate predictive power at extrapolated seeding conditions. The error
bars indicate one standard error. To see this figure in color, go online.
Fibril Breakage and Particle Concentration 2817TM-AFM single particle image analysis, mathematical sys-
tems modeling, statistical distribution analysis, and model
comparison. Using this approach, we have determined the
molar fibril particle concentration and revealed how the
rate of fibril fragmentation varies as a function of fibril
length and breakage position. Together, these insights reveal
the concentration of short amyloid fibrils and the rate of
their formation by fibril fragmentation under a given set
of experimental conditions. In our analysis, we show that
the complex process of fibril fragmentation involves a set
of nonequivalent rates with higher rates observed for sym-
metric breakages compared with asymmetric breakages
for the same fibril. In addition, progressively higher rates
of fragmentation were observed for longer fibrils than can
be explained by the assumption of a linear increase in the
number of fragmentation sites as fibrils grow in length
(25). The results indicate that b2m fibril fragmentation pro-
ceeds in a manner similar to a spontaneous fragmentation
process predicted for rigid rods that has been previously
described using statistical thermodynamic approaches (37).
In hemodialysis-related amyloidosis, b2m amyloid de-
posits accumulate predominantly in the joints (34). In theseFIGURE 6 Prediction of a biphasic fibril growth reaction. (a) Predicted
(purple) biphasic time evolution of the weight average fibril length of a
seeded fibril reaction undergoing simultaneous fibril fragmentation and
fibril growth. Measured weight average fibril lengths (each calculated
from 310 to 2000 individual fibrils on 4–12 images) are shown as black
crosses with error bars indicating one standard error. The shaded area indi-
cates 95% confidence functional prediction bounds. (b) Predicted average
fibril length compared with the measured average fibril length. Error bars
indicate one standard error. To see this figure in color, go online.areas, shear forces and mechanical stress may result in fibril
fragmentation, possibly playing a role in accelerating the
increase in fibril load of amyloid deposits in vivo. b2m fibrils
also fragment in the absence of additional mechanical
perturbation when they grow beyond a few micrometers in
length (32), which may reflect their limited stability toward
breakage under thermal motion. Even though the stirring-
induced turbulent flow applied here are unlikely to compare
directly with the stresses likely encountered by b2m amyloid
deposits under physiological conditions, the approach
presented here opens up a new opportunity to characterize
the stability of b2m amyloid fibrils toward breakage under
varying types and degrees of mechanical stresses, including
those that fibrillar assemblies are likely to encounter in vivo.
Such situations may be mimicked by alterations in the
stirring rate or the type of mechanical perturbation applied
(e.g. 41,42). In other biological situations, fibril fragmenta-
tion may be caused by other factors, such as enzymatic
action (43) and/or breakage due to fibril defects (27). For
example, enzymatic processing by the chaperone machinery
involving Hsp104 is known to fragment amyloid fibrils
formed from the yeast prion protein Sup35 (43). This
process is a key cellular mechanism that controls the gener-
ation of so-called prion propagons (31,40,44), which are
seeds that can propagate prion phenotypes from mother to
daughter cells. In the scenarios in which the predominant
cause of fibril fragmentation is different from the mechani-
cal perturbation performed here, it is possible that the
breakage rates as a function of length and position may be
different from the profile determined here for b2m. This
would result in distinct fibril size distributions and fibril
particle concentrations that could reflect the different
constructive or destructive biological roles of different
amyloid assemblies in different cellular environments.
Thus, the approach presented here, in which a full systems
modeling and image analysis enables the dimensions of
amyloid fibrils to be determined and predicted, will provide
the means to compare fibril lengths, particle concentrations,
and mechanisms of breakage for amyloid fibrils formedBiophysical Journal 105(12) 2811–2819
2818 Xue and Radfordfrom other protein and peptide sequences, as well as muta-
tions of these sequences and under different solution and
physical environments. The application of the approach
we present to other amyloid systems under varying mechan-
ical, enzymatic, thermal, or other environmental conditions,
therefore, could result in a new understanding of the
different amyloid fibrils’ stability toward fragmentation
under different stress conditions, and the consequences of
this for disease-associated and biologically beneficial amy-
loid materials.
Amyloid fibrils have potentials as a new class of engi-
neered nanomaterials due to their favorable physical proper-
ties (3). The fibrils’ stability toward breakage is also a key
parameter that must be characterized and optimized for
materials applications. The approach we have developed,
therefore, will be useful toward nanomaterials research in
determining and predicting the particle species distribu-
tions, particle concentrations, steady-state length distribu-
tions of fibrillar material, and how rapidly these materials
break when subjected to mechanical perturbation. In
essence, the approach developed here enables the fibril
material’s stability toward breakage under specific condi-
tions to be mapped, and its properties to be controlled in a
predictive manner.
In terms of amyloid disease in general, the particle con-
centration and the physical dimensions of fibril particles
impact on two vital disease-causing properties of amyloid:
the ability to seed the production of new amyloid material
via growth competent fibril ends, and to enhance the cyto-
toxic potential of amyloid either directly or via the produc-
tion of fibril ends that increase the probability of fibril
disassembly and the consequent release of toxic species
(12,18). The ability of fragmented fibrillar particles to act
as seeds of new amyloid (42) is dependent on the extent
to which fibrils have been fragmented (12), with shorter
fragmented fibrils being more effective in seeding for the
same effective mass of seeds, due to the increased number
of extension sites per mass of fibril material, compared
with their longer counterparts (12). Here, we have demon-
strated that the particle concentration information can be
obtained by single particle analysis of AFM images. We
show that particle concentration is a key quantitative factor
for describing the seeded growth of amyloid fibrils, and it
can be used as an excellent quantitative predictor of seeding
efficiency. Short fibrils have also been shown to be more
able to access cellular environments that are otherwise pro-
tected from large and entangled amyloid deposits (45–48),
offering an explanation of why some amyloid fibrils may
be infectious while others are not, and blurring the boundary
between prions and nontransmissible amyloid. Short, frag-
mented amyloid fibrils may assert distinct cytotoxic proper-
ties depending on their dimensions. For example, short
fibrils of b2m, a-synuclein, and hen egg white lysozyme
resulting from fibril fragmentation have been shown to
possess a higher cytotoxic potential to different cell linesBiophysical Journal 105(12) 2811–2819than longer fibrils of the same morphological type (12).
Accordingly, small cytotoxic oligomeric assembly interme-
diates have been shown to be fibrillar in nature (49). Short
fibrils of b2m have also been shown to disrupt model lipid
membranes, likely due to the presence of a larger number
of disruptive surfaces at fibril ends (19,50). Indeed, short
amyloid fibrils can act additionally as a reservoir of cyto-
toxic species, which can be shed from fibrillar ends (51).
The ability our approach offers to measure and to predict
changes in the amyloid populations, particle concentrations,
and species distributions either in a forward direction (elon-
gation growth) or in a backward direction (fibril fragmenta-
tion), as we have demonstrated for b2m fibril growth and
breakage, therefore, will be fundamental in understanding
amyloid assembly, the use of amyloid as a nanomaterial,
and amyloid-associated disease mechanisms. It will also
be critical in developing therapeutic approaches to control
the population of small cytotoxic and/or transmissible
fibrillar fragments, for example by stabilizing monomeric
precursors, preventing fibril elongation, or by reducing
fibrils’ susceptibility to fragment.SUPPORTING MATERIAL
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